Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dakshinesh Parameswaran
Institution:
SRM Institute of Science and Technology
Observed institutions:
SRM Institute of Science and Technology,
Tamil Nadu Dr. M.G.R. Medical University,
Nandha College of Pharmacy
ORCID:
0009-0000-3913-264X
Observed ORCID:
0009-0000-3913-264X
OpenAlex ID:
A5047022646
Charge-reversal nanoparticle-based microneedle systems: emerging trends and future perspectives in transdermal drug delivery
2026
·
Dakshinesh Parameswaran
, Suriya Prakaash Kannan
, et al.
·
Microsystem Technologies
·
1
Hydrogels in Pharmaceutical Formulation: Properties, formulation strategies, and drug delivery applications
2026
·
Suriya Prakaash Kannan
, Dakshinesh Parameswaran
, et al.
·
Biochemical and Biophysical Research Communications
Stimuli-responsive solid lipid nanoparticles for targeted drug delivery in biofilm-resistant infections: advances and challenges
2026
·
Dakshinesh Parameswaran
, Suriya Prakaash Kanan
, et al.
·
Drug Development and Industrial Pharmacy
QbD-Based Development of a pH-Responsive SLN-Loaded Hydrogel for Topical Management of Biofilm-Associated Diabetic Foot Ulcers
2026
·
Dakshinesh Parameswaran
, Suriya Prakaash Kannan
, et al.
·
Recent Advances in Drug Delivery and Formulation
Quality by design-based development of thermoresponsive injectable depots for sustained analgesic delivery
2026
·
Dakshinesh Parameswaran
, Suriya Prakaash Kannan
, et al.
·
Journal of Biomaterials Science Polymer Edition
Virtual Screening Approaches Towards the Discovery of Toll-like Receptor 7 (TLR7) Antagonists for the Management of Rheumatoid Arthritis During COVID Infection
2025
·
Thangavelu Prabha
, Saravanan Thangavelu
, et al.
·
Current Rheumatology Reviews
Design, Synthesis, and in vitro Evaluation of Derivatives of Quinoxaline-2- One as a Myeloperoxidase Modulator Using in silico Methods
2023
·
Dakshinesh Parameswaran
, Saravanan Thangavelu
, et al.
·
Current Bioactive Compounds
Molecular networking-based drug repurposing strategies for SARS-CoV-2 infection by targeting alpha-1-antitrypsin (SERPINA1)
2023
·
Dakshinesh Parameswaran
, Premkumar Kuduva Gurumoorthy
, et al.
·
Research Square
PDF
Show more works
View as search
Works count:
8
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type